Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495687 | SCV000578984 | likely benign | Breast-ovarian cancer, familial 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Invitae | RCV000554173 | SCV000635673 | likely benign | Hereditary breast and ovarian cancer syndrome | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000561383 | SCV000668518 | likely benign | Hereditary cancer-predisposing syndrome | 2016-12-23 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Synonymous alterations with insufficient evidence to classify as benign,In silico models in agreement (benign) |
Color | RCV000561383 | SCV000689138 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000607463 | SCV000723337 | likely benign | not specified | 2017-09-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |